ArticleFrontiers in oncology2026

Early Initiation of novel hormonal therapy is associated with improved survival in synchronous bone-metastatic hormone-sensitive prostate cancer: a retrospective cohort study from China.

Yize Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.